320 related articles for article (PubMed ID: 2871753)
1. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia.
Packer M; Gottlieb SS; Kessler PD
Am J Med; 1986 Apr; 80(4A):23-9. PubMed ID: 2871753
[TBL] [Abstract][Full Text] [Related]
2. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
3. Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure.
Packer M; Gottlieb SS; Blum MA
Am J Med; 1987 Mar; 82(3A):4-10. PubMed ID: 2882674
[TBL] [Abstract][Full Text] [Related]
4. Arrhythmias and mortality in congestive heart failure.
Kjekshus J
Am J Cardiol; 1990 May; 65(19):42I-48I. PubMed ID: 2159694
[TBL] [Abstract][Full Text] [Related]
5. Sudden cardiac death--an approach to management of the patient at risk.
Podrid PJ; Blatt CM
Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
[TBL] [Abstract][Full Text] [Related]
6. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death.
Bigger JT
Circulation; 1987 May; 75(5 Pt 2):IV28-35. PubMed ID: 3552300
[TBL] [Abstract][Full Text] [Related]
7. Ventricular arrhythmias in congestive heart failure.
Chakko S; de Marchena E; Kessler KM; Myerburg RJ
Clin Cardiol; 1989 Sep; 12(9):525-30. PubMed ID: 2571440
[TBL] [Abstract][Full Text] [Related]
8. [Management of ventricular arrhythmia in chronic congestive heart failure].
Pulignano G; Giovannini M; Del Sindaco D; Fera MS; Mazza A; Minardi G; Giovannini E
Clin Ter; 1998; 149(4):297-305. PubMed ID: 9866892
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new data.
Sueta CA; Patterson JH; Adams KF
Magnes Res; 1995 Dec; 8(4):389-401. PubMed ID: 8861138
[TBL] [Abstract][Full Text] [Related]
10. [Arrhythmias in chronic heart failure. Prognostic significance and treatment].
Koenig A; Chauvin M; Thévenin D; Brechenmacher C
Presse Med; 1991 May; 20(20):950-5. PubMed ID: 1676164
[TBL] [Abstract][Full Text] [Related]
11. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy.
Chakko CS; Gheorghiade M
Am Heart J; 1985 Mar; 109(3 Pt 1):497-504. PubMed ID: 3976476
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
13. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study].
Seipel L; Kühlkamp V
Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728
[TBL] [Abstract][Full Text] [Related]
14. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
[TBL] [Abstract][Full Text] [Related]
16. [Anti-arrhythmic therapy and cardiac failure].
Cosnay P; Babuty D; Charniot JC; Fauchier L; Fauchier JP
Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():35-41. PubMed ID: 8729298
[TBL] [Abstract][Full Text] [Related]
17. [Arrhythmias and heart failure].
Amann FW; Candinas R
Ther Umsch; 1993 Jun; 50(6):419-24. PubMed ID: 8351673
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
Das MK; Zipes DP
J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
Kochs M; Eggeling T; Hombach V
Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
[TBL] [Abstract][Full Text] [Related]
20. New approaches to drug selection and serial drug testing.
Somberg JC
J Clin Pharmacol; 1984 Jul; 24(7):320-7. PubMed ID: 6207209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
